IE 11 is not supported. For an optimal experience visit our site on another browser.

Pfizer begins low-dose Covid vaccine trials in young children


With more than 144 million adults now fully vaccinated against Covid-19, Pfizer is moving ahead with low-dose trials in children under 12-years-old and could begin mass vaccinations of kids in the fall. NBC News’ Maura Barrett is in Jefferson, Louisiana, where doctors are testing whether the vaccine is safe for children.